Optimer Biotechnology, Inc. (OBI) is a biotech company was formed in Taiwan in 2002. At beginning, it’s structured as a wholly owned subsidiary of Optimer Pharmaceuticals Inc. (OPTR) in San Diego, CA, USA. In November, 2009, it was spinning off from OPTR, forming a new management team with a mission to develop novel therapeutic agents for diseases that are currently lacking treatment options. The initial therapeutic focus will be cancer and osteoarthritis. OBI is positioned as a new product development company striving to improve health and quality of life through innovative and cost effective medicine.
Headquarters
19F, No.3, Yuan Qu Street, Nangang Software
Taipei City; Taipei City;
Contact Details: Purchase the OBI Pharma, Inc. report to view the information.
Website: http://www.obipharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service